Compare BIO & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | PCVX |
|---|---|---|
| Founded | 1952 | 2013 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.1B |
| IPO Year | N/A | 2020 |
| Metric | BIO | PCVX |
|---|---|---|
| Price | $264.92 | $53.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $358.50 | $98.33 |
| AVG Volume (30 Days) | 235.7K | ★ 1.1M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.74 | N/A |
| Revenue Next Year | $3.05 | N/A |
| P/E Ratio | $9.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $28.09 |
| 52 Week High | $343.12 | $75.33 |
| Indicator | BIO | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 40.24 | 41.02 |
| Support Level | $239.33 | $42.30 |
| Resistance Level | $289.61 | $56.04 |
| Average True Range (ATR) | 7.46 | 2.50 |
| MACD | 0.44 | -0.85 |
| Stochastic Oscillator | 19.99 | 7.80 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.